相关实验视频

Updated: Jul 9, 2025

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

通过抑制心肌细胞中的DNA损伤,GSTM2可缓解心力衰竭

Hongfei Xu¹, Zhen Wang¹, Yalin Wang²

¹Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhejiang University, School of Medicine, Number 79 Qingchun Road, Hangzhou, China.

Cell & bioscience

|December 1, 2023

概括

心力衰竭 (HF) 涉及复杂的分子变化. 这项研究确定了谷氨S转移酶M2-2 (GSTM2) 作为HF进展的关键因素,提供了潜在的治疗标.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
基因组学就是基因组学.

背景情况:

心力衰竭 (HF) 是一个全球性的健康问题,不完全理解病理机制.
识别HF中的分子变化对于开发有效治疗方法至关重要.

研究的目的:

创建人类心力衰竭组织的全面蛋白质和转录基因地图.
调查特定分子变化的作用,特别是谷氨S转移酶M2-2 (GSTM2) 在HF病变发生过程中的作用.

主要方法:

蛋白质组学和转录组学分析人类HF患者和健康供体样本.
在体内研究中,使用小鼠模型,通过横向大动脉收缩 (TAC) 诱导的HF.
评估DNA损伤,染色体外循环DNA (eccDNA) 生产和巨细胞炎症.

主要成果:

在HF组织中,在心房和心室之间观察到蛋白质和mRNA表达的显著差异.
心室组织显示了改变的代谢状态,而心房组织显示了激活的炎症途径.
谷氨S转移酶M2-2 (GSTM2) 水平在心室HF样本中下降.
在HF的小鼠模型中,GSTM2过度表达改善了心脏缩,DNA损伤,eccDNA产生和炎症.

结论:

这项研究提供了人类HF组织的详细分子地图.
谷氨酸S转移酶M2-2 (GSTM2) 在HF进展中起着关键作用.
GSTM2代表了对心力衰竭的有前途的新型治疗点.

关键词:

心脏过度缩小的情况.谷氨酸S转移酶M2-22-2是一种心脏衰竭是因为心脏衰竭.炎症炎症是一种炎症.蛋白质组学是指蛋白质组学.

更多相关视频

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...